Search

Joseph David Anthony

Examiner (ID: 12733, Phone: (571)272-1117 , Office: P/1761 )

Most Active Art Unit
1761
Art Unit(s)
1754, 1761, 1208, 1714, 1721, 1764, 2203, 1796
Total Applications
2751
Issued Applications
1907
Pending Applications
279
Abandoned Applications
592

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10820413 [patent_doc_number] => 20160166577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'TREATMENT OF PULMONARY FIBROSIS USING AN INHIBITOR OF CBP/CATENIN' [patent_app_type] => utility [patent_app_number] => 14/436653 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4940 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436653 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/436653
TREATMENT OF PULMONARY FIBROSIS USING AN INHIBITOR OF CBP/CATENIN Oct 20, 2013 Abandoned
Array ( [id] => 9422442 [patent_doc_number] => 20140107093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE' [patent_app_type] => utility [patent_app_number] => 14/053737 [patent_app_country] => US [patent_app_date] => 2013-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18193 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053737 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/053737
Compounds useful as inhibitors of ATR kinase Oct 14, 2013 Issued
Array ( [id] => 9409040 [patent_doc_number] => 20140100292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets' [patent_app_type] => utility [patent_app_number] => 14/048439 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5015 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048439 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/048439
Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets Oct 7, 2013 Abandoned
Array ( [id] => 9408984 [patent_doc_number] => 20140100236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets' [patent_app_type] => utility [patent_app_number] => 14/048445 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14285 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048445 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/048445
Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets Oct 7, 2013 Abandoned
14/040266 COMPOSITION AND METHOD OF TREATING SKIN CONDITIONS Sep 26, 2013 Abandoned
Array ( [id] => 9319364 [patent_doc_number] => 20140051702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis' [patent_app_type] => utility [patent_app_number] => 13/967389 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 48630 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967389 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/967389
Use of aminoindane compounds in treating overactive bladder and interstitial cystitis Aug 14, 2013 Issued
Array ( [id] => 9319395 [patent_doc_number] => 20140051733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/964731 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6418 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964731 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/964731
FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS Aug 11, 2013 Abandoned
Array ( [id] => 9496793 [patent_doc_number] => 08735611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Crystalline forms of cabazitaxel' [patent_app_type] => utility [patent_app_number] => 13/965015 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 8832 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965015 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/965015
Crystalline forms of cabazitaxel Aug 11, 2013 Issued
13/964033 USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE DISORDERS INCLUDING NICOTINE ADDICTION Aug 8, 2013 Abandoned
Array ( [id] => 9464012 [patent_doc_number] => 20140128439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'Methods for Treating Gout Flares' [patent_app_type] => utility [patent_app_number] => 13/961848 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12598 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961848 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/961848
Methods for Treating Gout Flares Aug 6, 2013 Abandoned
Array ( [id] => 9307263 [patent_doc_number] => 20140045937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID' [patent_app_type] => utility [patent_app_number] => 13/960999 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4576 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960999 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/960999
METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID Aug 6, 2013 Abandoned
Array ( [id] => 10102661 [patent_doc_number] => 09138431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Methods of treatment of histamine H-4 receptor-related pruritus' [patent_app_type] => utility [patent_app_number] => 13/960114 [patent_app_country] => US [patent_app_date] => 2013-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960114 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/960114
Methods of treatment of histamine H-4 receptor-related pruritus Aug 5, 2013 Issued
Array ( [id] => 9149077 [patent_doc_number] => 20130303600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/941932 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3772 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/941932
Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients Jul 14, 2013 Issued
Array ( [id] => 9384577 [patent_doc_number] => 20140088059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'Compositions and Methods for Localized Drug Delivery through Mammary Papillae' [patent_app_type] => utility [patent_app_number] => 13/942686 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 21281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942686 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/942686
Compositions and methods for localized drug delivery through mammary papillae Jul 14, 2013 Issued
Array ( [id] => 12942406 [patent_doc_number] => 09833426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function [patent_app_type] => utility [patent_app_number] => 14/411169 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5173 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411169 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/411169
Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function Jun 27, 2013 Issued
Array ( [id] => 10272651 [patent_doc_number] => 20150157648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2' [patent_app_type] => utility [patent_app_number] => 14/410754 [patent_app_country] => US [patent_app_date] => 2013-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26478 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410754 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/410754
NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2 Jun 25, 2013 Abandoned
Array ( [id] => 9263327 [patent_doc_number] => 20130345255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'TRPV1 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/922442 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25862 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922442 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/922442
TRPV1 antagonists Jun 19, 2013 Issued
Array ( [id] => 12924469 [patent_doc_number] => 09827201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Natural lubricant for direct compression and method for preparing natural tablet using the same [patent_app_type] => utility [patent_app_number] => 13/871529 [patent_app_country] => US [patent_app_date] => 2013-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3184 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13871529 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/871529
Natural lubricant for direct compression and method for preparing natural tablet using the same Apr 25, 2013 Issued
Array ( [id] => 13644611 [patent_doc_number] => 09848599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Co-crystals of 3-iodopropynyl butylcarbamate [patent_app_type] => utility [patent_app_number] => 14/391504 [patent_app_country] => US [patent_app_date] => 2013-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 7196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391504 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/391504
Co-crystals of 3-iodopropynyl butylcarbamate Apr 8, 2013 Issued
Array ( [id] => 11886919 [patent_doc_number] => 09757465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Composition comprising an organic diluent and a cellulose ether' [patent_app_type] => utility [patent_app_number] => 14/390049 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12331 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390049 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/390049
Composition comprising an organic diluent and a cellulose ether Apr 7, 2013 Issued
Menu